# Toleranzia AB jobs and careers

> 0 open roles at Toleranzia AB as of October 24, 2026. Source: https://www.thejobsmap.com/company/toleranzia-ab

Toleranzia develops protein-based antigen-specific immune tolerogens to cure patients with autoimmune diseases. The drugs have the potential to become the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being developed. The company has a lead project in myasthenia gravis as well as a second project in ANCA vasculitis. Toleranzia is listed on the Nasdaq First North Growth Market and backed by strongly committed renowned specialist investors.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Sweden |
| Founded | 2011 |
| Employees | 1 to 10 |
| Total funding | $71K |
| Industries | Business Development, Pharmaceutical |
| Website | https://toleranzia.se |

## Leadership

- Bjorn Lowenadler, Chief Business Officer

## Common questions

### Is Toleranzia AB hiring right now?

Toleranzia AB has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Toleranzia AB's careers site.

### Where is Toleranzia AB headquartered?

Toleranzia AB is headquartered in Sweden and was founded in 2011.

### Who leads Toleranzia AB?

Bjorn Lowenadler, Chief Business Officer, is at the top of Toleranzia AB's org chart.

### How do I apply for a job at Toleranzia AB?

Pick a role on Toleranzia AB's TheJobsMap page and select Apply. Every listing links to the original posting on Toleranzia AB's own careers site, so you apply directly with the employer.